ProNAi Therapeutics, Inc., a private DNAi cancer drug development company, recently concluded its initial human clinical trial of PNT2258. The company also expanded its management team with the recent appointments of board member and venture capital investor Mina Sooch, MBA, as President and CEO, and Dr. Richard Messmann, MD, as Chief Medical Officer.
FOR IMMEDIATE RELEASE – November 5, 2012 – Ann Arbor, Mich. — At its annual meeting, the Michigan Venture Capital Association (MVCA) awarded Venture Financing of the Year to CytoPherx, the MVCA 100 to mophie and Above and Beyond to Don Walker of Arbor Partners. It also announced its 2013 executive committee and board […]
Two MVCA members, Augment Ventures and MK Capital recently made investments in LLamasoft, Inc., the global leader in supply chain design software. LLamasoft enables companies to model, optimize and simulate their supply chain network, leading to major improvements in cost, service, sustainability, and risk mitigation, with unparalleled supply chain design and predictive analytics solutions. “LLamasoft […]
Renaissance Venture Capital Fund recently made its first investment commitment from its Renaissance II fund. The commitment was made to Allos II, a Cincinnati and Indianapolis-based venture capital fund targeting investments in early-stage technology companies based in the Midwest. The fund’s investor group, which includes institutional investors such as Indiana University Foundation, Purdue University and […]
On August 23rd, Startup Michigan and turnstone will host an educational symposium on the Impact of the JOBS Act on Michigan Startups. This event will provide you with the knowledge base necessary to understand how your startup and the Michigan startup community can benefit from the JOBS Act. This event will be held on Thursday, August 23rd, 8:30AM-4PM in […]
Michigan-based start-ups have received about $90 million of venture capital investment in 17 different companies.
Renaissance Venture Capital Fund (RVCF) is a venture capital role model for Detroit.
The Michigan Venture Capital Association’s (MVCA) programs to develop the state’s investment community are helping venture capitalists and their portfolio companies attract and retain top talent.
At its June 20, 2012, meeting, the AzulStar board of directors unanimously elected Richard N. Brouwer to be its Chief Executive Officer and Chief Operating Officer.
At its June 20, 2012, meeting, the AzulStar board of directors unanimously elected Richard N. Brouwer to be its Chief Executive Officer and Chief Operating Officer.